𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of quetiapine in psychotic Parkinsonian patients with and without dementia

✍ Scribed by T. Prohorov; C. Klein; A. Miniovitz; E. Dobronevsky; J. M. Rabey


Publisher
Springer
Year
2005
Tongue
English
Weight
209 KB
Volume
253
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The effect of quetiapine on psychosis an
✍ Sujana Reddy; Stewart A. Factor; Eric S. Molho; Paul J. Feustel πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

Recently, several small studies have indicated that quetiapine may be useful in the treatment of drug-induced psychosis in patients with PD. However, there have been questions related to atypical antipsychotic therapy and patient selection and how that may affect response and tolerability, especiall

The effect of quetiapine on aggression a
✍ Celso Arango; Miguel Bernardo πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 1 views

## Abstract A post hoc analysis of data from three placebo‐controlled, double‐blind, randomized trials was carried out to determine the efficacy of quetiapine in aggression and hostility in patients with schizophrenia. Quetiapine treatment induced statistically significantly greater improvements in

Effect of quetiapine in psychotic Parkin
✍ Jose M. Rabey; Tatiana Prokhorov; Ala Miniovitz; Eugenia Dobronevsky; Colin Klei πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 1 views

## Abstract This double‐blind randomized study examined the effect of quetiapine (QTP) on drug‐induced psychosis (DIP) in Parkinson's disease (PD). Conventional antipsychotic drugs are associated with adverse extrapyramidal effects. QTP is a new atypical antipsychotic drug used in the treatment of

Effects of rivastigmine in patients with
✍ David Burn; Murat Emre; Ian McKeith; Peter Paul De Deyn; Dag Aarsland; Chuanchie πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 1 views

## Abstract We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, provided benefits in patients with and without visual hallucinations in a population with dementia associated with Parkinson's disease (PDD). This was a 24‐week doub

Patients with Parkinson's disease dement
✍ Phillip Fletcher; Alison Leake; Marie-Helene Marion πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 880 KB

originating from the peripheral rather than central retina. Correspondingly, VEP was also reported to be normal in MSA patients as it measures activity mainly originating from the central visual field. 7 Future studies will have to determine whether MSA patients show predominantly peripheral visual